Harvard Bioscience (HBIO) Common Equity (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Common Equity of $10.0 million for Q1 2026, down 32.28% year-over-year from $14.8 million in Q1 2025, and down 26.85% quarter-over-quarter from $13.7 million in Q4 2025.
Harvard Bioscience (HBIO) Common Equity (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Common Equity for 17 consecutive years, with $10.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Common Equity fell 32.28% year-over-year to $10.0 million; the TTM figure through Mar 2026 stood at $10.0 million (down 32.28% YoY), while the FY2025 annual figure was $13.7 million, down 78.32% from the prior year.
- Common Equity retreated to $10.0 million in Q1 2026 per HBIO's latest filing, from $13.7 million in the prior quarter.
- Across five years, Common Equity topped out at $77.5 million in Q2 2022 and bottomed at $10.0 million in Q1 2026.
- Historically, Common Equity has averaged $54.6 million across 5 years, with a median of $68.8 million in 2024.
- Annual changes were most pronounced in 2023 — Common Equity climbed 3.21% — and 2025, when it slumped 78.46%.
- Harvard Bioscience's Common Equity stood at $72.2 million in 2022, then climbed by 1.18% to $73.1 million in 2023, then dropped by 13.32% to $63.3 million in 2024, then slumped by 78.32% to $13.7 million in 2025, then dropped by 26.85% to $10.0 million in 2026.
- Business Quant data shows HBIO's Common Equity at $10.0 million in Q1 2026, $13.7 million in Q4 2025, and $14.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 18.30 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 24.42 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 21.60 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 6.59 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 19.08 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 2.99 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 4.80 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 8.24 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 6.21 Bn |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | 7.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.42 Mn |
| Mar 31, 2026 | 10.05 Mn |
| Dec 31, 2025 | 13.73 Mn |
| Sep 30, 2025 | 14.07 Mn |
| Jun 30, 2025 | 15.73 Mn |
| Mar 31, 2025 | 14.84 Mn |
| Dec 31, 2024 | 63.34 Mn |
| Sep 30, 2024 | 65.32 Mn |
| Jun 30, 2024 | 67.25 Mn |
| Mar 31, 2024 | 68.81 Mn |
| Dec 31, 2023 | 73.07 Mn |
| Sep 30, 2023 | 74.29 Mn |
| Jun 30, 2023 | 75.39 Mn |
| Mar 31, 2023 | 74.34 Mn |
| Dec 31, 2022 | 72.22 Mn |
| Sep 30, 2022 | 71.98 Mn |
| Jun 30, 2022 | 77.50 Mn |
| Mar 31, 2022 | 76.38 Mn |
| Dec 31, 2021 | 83.40 Mn |
| Sep 30, 2021 | 76.89 Mn |